| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Biller Scott is a Chief Scientific Officer at AGIOS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 7, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 3,000 | $81.81 | $245,430.00 | -5.0% | |
| Apr 5, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 3,000 | $75.20 | $225,607.00 | -1.3% | |
| Mar 5, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 3,000 | $83.08 | $249,229.00 | -1.4% | |
| Feb 5, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 3,000 | $76.04 | $228,127.87 | -1.4% | |
| Jan 10, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 3,000 | $65.00 | $195,000.00 | -5.4% | |
| Dec 1, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 2,146 | $60.79 | $130,458.98 | -9.3% | |
| Nov 1, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 2,146 | $62.69 | $134,522.26 | -6.7% | |
| Oct 4, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 10,470 | $70.00 | $732,900.00 | -100% | |
| Oct 2, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 2,146 | $67.23 | $144,275.58 | -14.6% | |
| Sep 11, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 15,000 | $65.00 | $975,000.00 | -58.9% |